Fda gives go-ahead for xbiotech's candidate therapy for phase i/ii double-blind placebo controlled study in pancreatic cancer

Xbiotech's new drug to enter clinical studies in combination therapy for pancreatic cancer xbiotech's new drug to enter clinical studies in combination therapy for pancreatic cancer

XBIT Ratings Summary

XBIT Quant Ranking